Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage

Aaron Kesselheim and colleagues examine orphan-designated drugs approved between 2009 and 2015 in the United States.

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS Med
Egile Nagusiak: Kesselheim, Aaron S., Treasure, Carolyn L., Joffe, Steven
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2017
Gaiak:
Policy Forum
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5207392/
https://ncbi.nlm.nih.gov/pubmed/28045970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002190
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak